HR 4124
117th Congress
House
Health
Administrative law and regulatory procedures
Aging
Appropriations
Budget deficits and national debt
Cancer
Child health
Computers and information technology
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Education programs funding
Environmental health
Executive agency funding and structure
Food and Drug Administration (FDA)
Genetics
Government trust funds
Health care costs and insurance
Health information and medical records
Health personnel
National Biomedical Research Act
Introduced: June 24, 2021
Introduced by:
Clarke, Yvette D.
Democratic
· New York
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 25, 2021
Referred to the Subcommittee on Health.
Jun 24, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Rules, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 24, 2021
Introduced in House
Plain-English summary
National Biomedical Research Act
This bill establishes and makes deposits through FY2031 into the Biomedical Innovation Fund for initiatives at the National Institutes of Health and the Food and Drug Administration. The fund supports (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; and (4) other innovative medical research.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4
Cosponsors
1